Malignant melanoma (MM) in humans develops within a complex aetiologic framework of genetic, host, and environmental factors (Goldstein & Tucker, 2001 ).
The strongest environmental risk factor is sun exposure (Sulaimon et al., 2003) . In the mouse, wild type animals are resistant to MM development even when exposed to repeated treatments with ultraviolet radiation (UVR) (Gallagher et al., 1984) .
However chronic UVR treatment regimens have increased MM penetrance by up to 26% in mice carrying various transgenes capable of inducing spontaneous MM development, or melanocytic hyperplasia, e.g. Tyr-SV40Tag (Kelsall & Mintz, 1998; Klein-Szanto et al., 1994) , TPras (Broome Powell et al., 1999) and Mt-Hgf/Sf (Noonan et al., 2000) mice. More recently, Noonan et al. (2001) showed that a single neonatal dose of 9 kJ/m 2 was far more effective than chronic treatments at inducing MM in the Mt-Hgf/Sf transgenics. Kannan et al. (2003) It has previously been demonstrated that pigmented Tyr-SV40Tag mice treated with repeated neonatal UVR doses from days 3-10, show increased rates of MM compared to untreated animals (Kelsall & Mintz, 1998; Klein-Szanto et al., 1994) .
However, these mice did not develop melanomas over their limited lifespan when treated with a single neonatal dose. All subsequent studies have used albino mouse strains for neonatal UVR experiments.
Evidence suggests that the Ras pathway is pivotal for MM development.
The RAS family is comprised of NRAS, HRAS, KRAS, which are all involved in the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) signalling cascades (Busca et al., 2000) . There is a high frequency of BRAF and NRAS mutation in melanocytic nevi and MM (e.g. Davies et al., 2002; Pollock et al., 2003 and reviewed in de Snoo & Hayward, 2005; Rodolfo et al., 2004) . Human cutaneous MM from chronically sun-exposed body sites commonly harbour NRAS mutations, thus supporting a possible role for solar UVR in their genesis (Jiveskog et al., 1998; van Elsas et al., 1996) . As discussed above, activated Hras has been shown to be a potent amplifier of tumorigenesis in genetically modified mice carrying deletions of the Ink4a or Arf genes, however, to date there have been no reports assessing the capability of Hras alone to induce MM in mice treated with a neonatal dose of UVR. We thus treated brown mice (mixed C3H/Sv129 strain background) carrying a melanocyte-specific mutant Hras (G12V) transgene (TPras) (Powell et al., 1995) , with a similar neonatal UVR regimen to that used by Noonan et al. (2001) .
We used an apparatus that holds 3 Phillips FS40 (Andover, MA, USA) UVB lamps mounted 34 cm above the mice. Pups (2-3 days old) were exposed for 16 minutes, to
give a total dose of 8.15 kJm -2 (UVA 320-400 nm, 2.36 kJm -2 , UVB 280-320 nm, 5.77 kJm -2 , UVC 250-280, 0.02 kJm -2 ), a slightly lower dose than previously used (Noonan et al., 2001) . This is markedly higher penetrance and earlier average age of onset than that of the similarly treated Mt-Hgf/Sf transgenics (Noonan et al., 2001; Recio et al., 2002) . Previous experiments in which our pigmented TPras animals were exposed to a chronic UVR regimen (5.6-8.06 kJm 2 biweekly for 38 weeks) did not induce MM (Broome Powell et al., 1999) . To assess the reasons for the differences in UVR-induced MM susceptibility observed, we examined skin sections from adult
TPras and neonatal TPras and wild type littermates. Adult TPras skin was highly pigmented, with scattered melanin in the upper dermis and large aggregates in the deep dermis (Fig 2a) . In contrast, 2-day-old TPras skin lacked visible melanin (Fig   2b) . The majority of melanocytes in neonatal skin of wild-type mice were located within hair follicles (Fig 2c) , whereas there were noticeably more melanocytes in the extra-follicular dermis of TPras mice (Fig 2d) .
UVR-induced MM ranged in size from 0.4-1.2 cm 2 and were heavily pigmented (Fig 2e) . These lesions appear to originate in the dermis (Fig 2f) , lack the classical junctional changes observed in human MM (Fig 2g) , and contain large atypical melanocytes (Fig 2h) . The dermal origin of these lesions reflects the location of the hyperplastic melanocytes in the adult animals (i.e. not along the basal layer as in humans) (Powell et al., 1995) . Hyperplasia of the epidermis was frequently observed in UVR-treated mouse skin (Fig 2g) .
The mutation status of the Cdkn2a locus in these tumours was determined by immunohistochemistry (IHC) and analysis of tumour DNA and RNA (Fig 3 and table   Ι ). No genomic deletion was observed and both transcripts were expressed in 2 out of 3 tumours examined. Ink4a was detected in 5 out of 7 MM by IHC. The melanoma cell-line derived from one of the tumours lost Ink4a as it was passaged.
This study confirms the importance of a single neonatal UVR dose, compared with chronic UVR regimens in adult mice, for MM induction. The reason neonatal melanocytes are more susceptible to transformation than adult melanocytes is unclear, but it may be that they are immature and not fully differentiated, and/or, some are still located in the epidermis in newborn skin whereas in adult dorsal skin they are invariably located in the dermis (reviewed in Hirobe, 1995) .
In conclusion, our work has demonstrated that neonatal UVR treatments are probably as effective at inducing MM in pigmented mice as albino strains.
Furthermore, we have shown that RAS activation alone is sufficient to predispose melanocytes to UVR-induced transformation, and, although the precise mechanism is yet to be determined, it does not always involve loss of Ink4a or Arf. It may be that Cdkn2a copy number was assessed by multiplex semi-quantitative PCR with exon specific primers using Gapdh as control (primers available on request). Expression levels of Ink4a and Arf were determined by Quantitect SYBR Green (Qiagen, Germany) real-time PCR, using a Rotorgene 3000 cycler (Corbett Research, Australia). Data was analysed using Rotorgene 6 software (Corbett research) with the Pfaffl equation method (Pfaffl, 2001 ). β-actin was used as a PCR control, and
MMs were compared to wild type skin expression, with the relative expression level assessed to be upregulated (>2.0-fold); roughly equal (within 0.5-to 2.0-fold); or downregulated (<0.5-fold). Lesions MM-4 and MM-5 originated in the same animal.
Immunohistochemistry (IHC) for Ink4a was performed as described in Figure 3 .
Genomic PCR qRT-PCR IHC Percent Stromal
